BiondVax Pharmaceuticals Ltd.
http://www.biondvax.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From BiondVax Pharmaceuticals Ltd.
What Does 2019 Hold For Biopharma?
Industry executives, consultants and analysts speculate on what they believe the big themes, trends and events will be this year.
Imutex's Universal Flu Vaccine Inches Forward On New Data
The Imutex joint venture between hVIVO and the SEEK Group updates promise of its universal flu vaccine candidate after additional data from a Phase IIb study showed a statistically significant effect on its primary endpoint.
Scrip Asks... What Will 2019 Hold For Biopharma? Part 1: Therapeutic Advances
Scrip journalists asked industry executives, consultants and analysts what they believe the big themes, trends and events will be in 2019. Here's what they told us about advances in therapeutic technologies and areas of clinical innovation.
Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom
Private Company Edition: Investments by CIRM, the GHIT fund and the European Investment Bank back early-stage science and treatments for neglected diseases. Also, Versant Ventures raises $700m in two funds. In VC deals, Akero raised $70m, Impel NeuroPharma brought in $67.5m.
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
-
Drug Delivery
- Macromolecule
-
Biotechnology
- Drug Discovery Tools
- Large Molecule